Shea Butter (Butyrospermum parkii)

What is it?

Shea butter is a rich, emollient fat extracted from the nuts of the African shea tree (Vitellaria paradoxa, formerly Butyrospermum parkii). It has been used for centuries in African traditional medicine for skin healing, moisturization, and sun protection. Shea butter's unique composition includes a high concentration of unsaponifiable matter (5-17%) — primarily triterpenes (lupeol, alpha-amyrin, beta-amyrin) and cinnamic acid esters — which distinguishes it from other plant fats and is responsible for its exceptional anti-inflammatory and healing properties. The fatty acid profile consists primarily of oleic acid (40-60%) and stearic acid (20-50%), with smaller amounts of linoleic and palmitic acids. Shea butter contains natural UV-absorbing compounds (cinnamic acid esters) that provide modest SPF 3-4 protection. Its triterpene fraction has been clinically shown to inhibit inflammatory enzymes (COX-2, 5-LOX), reduce edema, and accelerate wound healing. Shea butter's occlusive properties reduce transepidermal water loss while its emollient qualities soften and smooth the skin surface. It is non-comedogenic for most skin types and well-tolerated even on compromised or sensitive skin.

How It Works

1. 1

   Heavy Occlusion

   Creates a thick lipid barrier that prevents TEWL and keeps PDRN in contact with skin cells longer.

2. 2

   COX-2 Inhibition

   Triterpenes (lupeol, amyrins) inhibit COX-2 inflammation — a separate pathway from PDRN's adenosine signaling.

3. 3

   Emollient Smoothing

   Fills gaps between desquamating cells, smoothing skin texture while PDRN rebuilds the dermal structure beneath.

4. 4

   Mild UV Filter

   Cinnamic acid esters provide modest photoprotection, helping shield PDRN-regenerated collagen from UV degradation.

Role in PDRN

Shea butter serves as an exceptional occlusive partner for PDRN in skincare routines, particularly for dry, mature, or post-procedure skin. After PDRN serum activates fibroblasts and stimulates collagen synthesis through adenosine A2A receptor signaling, shea butter applied as a final step creates a protective seal that serves dual purposes: it prevents the PDRN from evaporating before full absorption, and it delivers its own potent anti-inflammatory triterpenes that complement PDRN's cytokine-modulating activity. The lupeol in shea butter has demonstrated direct anti-inflammatory activity through COX-2 inhibition — a different pathway from PDRN's adenosine receptor mechanism — providing broader inflammation control. Shea butter's rich emollient texture is particularly beneficial for areas where PDRN is used to address aging: the neck, décolletage, hands, and body skin, where the thicker consistency provides both occlusion and comfort.

Clinical Data

A 2010 study published in the Journal of Oleo Science confirmed that shea butter's triterpene fraction significantly reduced inflammation in a carrageenan-induced edema model, with anti-inflammatory activity comparable to indomethacin. Research in the American Journal of Life Sciences (2016) demonstrated that shea butter accelerated wound healing and increased collagen deposition in animal models. A clinical study in the Journal of Clinical and Aesthetic Dermatology (2019) showed that shea butter-containing formulations significantly improved skin barrier function and reduced TEWL after 4 weeks of daily use. The wound-healing and anti-inflammatory benefits of shea butter are directly synergistic with PDRN's regenerative mechanism.